Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection

Abstract excerpt

BACKGROUND: Treatment in bipolar disorder (BD) is commonly applied as a multimodal therapy based on decision algorithms that lack an integrative understanding of molecular mechanisms or a biomarker associated clinical outcome measure. Pharmacogenetics/genomics study the individual genetic variation associated with drug response. This selective review of pharmacogenomics and pharmacogenomic testing (PGT) in BD...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bipolar Disorder and Treatment
• Share to Genetic Associations and Epidemiology
• Share to Pharmacogenetics and Drug Metabolism